6 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Unknown 6 |
Follow Sofosbuvir: new trials by email Literature Review of Sofosbuvir trials Research Report on Sofosbuvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir - Hepatitis C, Cirrhosis | Phase 4 | Unknown | Peking University People's Hospital | 100 | 2022-09-01 | 2022-07-21 |
| Same-visit Hepatitis C Testing and Treatment (The QuickStart Study) OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid), Sofosbuvir/Velpatasvir (Gilead) - Hepatitis C | Phase 4 | Unknown | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 1800 | 2022-03-09 | 2023-11-13 |
| Effect Of DAAs For Treatment Of HCV On Normal Kidney Sofosbuvir 400 MG Oral Tablet,, Ombitasvir/paritaprevir/ritonavir - Antiviral Drug Adverse Reaction | Phase 4 | Unknown | Assiut University | 100 | 2017-10-01 | 2017-09-29 |
| Transplanting Hepatitis C Positive Organs Sofosbuvir/velpatasvir, Monitoring - Hepatitis C, Awaiting Organ Transplant | Phase 4 | Unknown | Brigham and Women's Hospital | 148 | 2017-03-01 | 2022-10-12 |
| Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C Sofosbuvir and Ledipasvir or sofosbuvir and daklatasuvir - Hepatitis C | Phase 4 | Unknown | Sherief Abd-Elsalam | 1200 | 2017-01-01 | 2018-08-27 |
| Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy Sofosbuvir 400mg / Ledipasvir 90 mg (FDC) - Chronic Hepatitis C | Phase 4 | Unknown | Wilhelminenspital Vienna | 40 | 2015-09-01 | 2015-12-23 |
Hepatitis C (5) · Fibrosis (1) · Hepatitis C, Chronic (1) · Substance Abuse, Intravenous (1)
Assiut University (1) · Brigham and Women's Hospital (1) · Macfarlane Burnet Institute for Medical Research and Public Health Ltd (1) · Peking University People's Hospital (1) · Sherief Abd-Elsalam (1) · Wilhelminenspital Vienna (1)
Australia (1) · Austria (1) · Egypt (1) · United States (1)
Huiying Rao, Dr. (1) · Joseph Doyle, MBBS, PhD (1) · Lindsey Baden, MD (1) · Michael Gschwantler, Prof. MD (1) · Mohamed Alboraie, MD (1) · Mohammed M Abdallah, MD (1) · Rehab Badawi, MD (1) · Sherief Abd-Elsalam, MD (1) · Zainelabdeen A Sayed, MD (1)
PMID 29316001, PMID 30946553, PMID 38960465, PMID 40607684, PMID 41255102